Search

Your search keyword '"Colombo, Eleonora"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Colombo, Eleonora" Remove constraint Author: "Colombo, Eleonora"
236 results on '"Colombo, Eleonora"'

Search Results

3. Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients

5. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis

6. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

11. Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients

12. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

14. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

19. Total Synthesis of an Epothilone Analogue Based on the Amide‐Triazole Bioisosterism.

20. QSM-detected iron accumulation in the cerebellar gray matter is selectively associated with executive dysfunction in non-demented ALS patients.

21. Longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in non-demented ALS patients

22. Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis.

24. An exploratory study on counterfactual thinking in amyotrophic lateral sclerosis

26. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis

28. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

31. Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation

32. The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis

33. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

34. Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients

35. Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients.

37. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis

38. Single task-level, 2SD-based cutoffs for the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS).

40. Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis

41. Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis

42. Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire

44. Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis

45. Dehydroroyleanone as a Building Block for a Drug Delivery Platform Based on Self-Assembled Nanoparticles: Structural Studies and Chemical Modification

46. Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis

47. Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis

49. Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis

50. Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson’s Disease Patients

Catalog

Books, media, physical & digital resources